Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Back
Association details:
Biomarker:
POU5F1 overexpression + NANOG overexpression
Cancer:
Oral Cancer
Drug:
cisplatin
(
DNA synthesis inhibitor
)
Direction:
Resistant
Evidence:
Evidence Level:
Resistant: C3 – Early Trials
New
Source:
Wiley Online Library
Title:
Markedly increased Oct4 and Nanog expression correlates with cisplatin resistance in oral squamous cell carcinoma
Excerpt:
Notably, up‐regulation of Oct4 and Nanog expression was significantly observed in cisplatin‐resistant patients with OSCC (**P<0.01).
DOI:
10.1111/j.1600-0714.2011.01015.x
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login